Sensory Stimulation Systems, and GENUS, refer to a noninvasive procedure, i.e., a "digital therapeutic," being developed by Cognito Therapeutics. The company developed a wearable GammaSense ...

Aspects of the research and practice paradigm known as the diffusion of innovations are applicable to the complex context of health care, for both explanatory and interventionist purposes. This ...

Discover Gemini Diffusion, the AI model transforming AI text generation with speed, precision, and creative freedom. Gemini Diffusion text ...

Inverness Graham has acquired Cognito Forms, a Columbia, South Carolina-based provider of low code/no-code workflow automation solutions. No financial terms were disclosed. “As organizations ...

Discover how Mercury’s diffusion-based LLMs are 10x faster than Transformers, reshaping AI for text, image, and video generation.

Mr. Howell joined Cognito in October 2023 as Chief Commercial Officer. As Cognito nears enrollment completion in the HOPE pivotal study for Spectris™, its lead disease-modifying candidate for ...

Cognito plans to expand its mental health services across Canada this year. Victoria-based Cognito Health has secured $2 million CAD in seed funding for its all-in-one virtual mental healthcare ...

Hardly any other AI topic invites more experiments than image generators. However, they are not only available on the web, but also for your own (powerful) PC. We show what's needed for this.

Just as a new wave of approved drugs for Alzheimer’s reaches patients, Cognito Therapeutics has raised a fresh $35 million to advance its alternative treatment.

In addition, Cognito said in Tuesday’s announcement that it plans to use the biomarker analyses to look for indicators of Alzheimer’s progression and to spot new disease areas that may also ...

Cognito Therapeutics has spent the better part of the last decade developing neuromodulation technology that it claims could stop and even reverse the progression of Alzheimer’s and other ...